TITLE

Platform Presentations

PUB. DATE
November 2007
SOURCE
Multiple Sclerosis (13524585);Nov2007, Vol. 13 Issue 9, p1217
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on medical topics which include the examination of inducible over-expression of CXCL1 by astrocytes if it can also be neuroprotective, the potential generic predisposition and cognitive impairment that may be experienced by patients with multiple sclerosis, and the thickness of retinal nerve fiber layer which may be induced by brain atrophy in multiple sclerosis.
ACCESSION #
27505717

 

Related Articles

  • Investigating perturbed pathway modules from gene expression data via structural equation models. Pepe, Daniele; Grassi, Mario // BMC Bioinformatics;2014, Vol. 15 Issue 1, p1 

    Background It is currently accepted that the perturbation of complex intracellular networks, rather than the dysregulation of a single gene, is the basis for phenotypical diversity. High-throughput gene expression data allow to investigate changes in gene expression profiles among different...

  • Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. Booth, D. R.; Arthur, A. T.; Teutsch, S. M.; Bye, C.; Rubio, J.; Armati, P. J.; Pollard, J. D.; Heard, R. N. S.; Stewart, G. J. // Journal of Molecular Medicine;Oct2005, Vol. 83 Issue 10, p822 

    Multiple sclerosis (MS) is an enigmatic disease of the central nervous system resulting in sclerotic plaques with the pathological hallmarks of demyelination and axonal damage, which can be directly or indirectly orchestrated by cells from the peripheral circulation. The majority of patients...

  • Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis. Hamid, Kabir Magaji; Nejati, Ahmad; Shoja, Zabihollah; Mollaei-Kandelousd, Yaghoub; Doosti, Rozita; Mirshafiey, Abbas; Tafakhori, Abbas; Sahraian, Mohammad Ali; Marashi, Sayed Mahdi; Hamid, Kabir Magajir // Iranian Journal of Allergy, Asthma & Immunology;Feb2016, Vol. 15 Issue 1, p75 

    Multiple sclerosis is a chronic inflammatory disease of the central nervous system characterized by a complex immune response. Because of the complex nature of MS pathogenesis, a panel of biomarkers derived from different platforms will be required to reflect disease-related alterations....

  • New approaches to investigating heterogeneity in complex traits. Bomprezzi, R.; Kovanen, P.E.; Martin, R. // Journal of Medical Genetics;Aug2003, Vol. 40 Issue 8, p553 

    Evaluates how new methodologies such as gene expression profiling can be exploited to gain insight into complex diseases, using multiple sclerosis as a prototype. Early steps in molecular genetic investigations; Linkage analysis aimed at identifying genetic markers that are coinherited with...

  • Autoimmunity: MS microarrays. Brazil, Melanie // Nature Reviews Immunology;Jun2002, Vol. 2 Issue 6, p384 

    Discusses research being done on the gene expression in multiple sclerosis microarrays. Reference to a study conducted by C. Lock published in the 'Nature Medicine.'

  • Understanding Autoimmune Mechanisms in Multiple Sclerosis Using Gene Expression Microarrays: Treatment Effect and Cytokine-related Pathways. Achiron, A.; Gurevich, M.; Magalashvili, D.; Kishner, I.; Dolev, M.; Mandel, M. // Clinical & Developmental Immunology;Sep-Dec2004, Vol. 11 Issue 3/4, p299 

    Multiple sclerosis (MS) is a central nervous system disease in which activated autoreactive T-cells invade the blood brain barrier and initiate an inflammatory response that leads to myelin destruction and axonal loss. The etiology of MS, as well as the mechanisms associated with its unexpected...

  • Simvastatin inhibits interferon-γ-induced MHC class II up-regulation in cultured astrocytes. Zeinstra, Esther; Wilczak, Nadine; Chesik, Daniel; Glazenburg, Lisa; Kroese, Frans G. M.; De Keyser, Jacques // Journal of Neuroinflammation;2006, Vol. 3, p16 

    Based on their potent anti-inflammatory properties and a preliminary clinical trial, statins (HMGCoA reductase inhibitors) are being studied as possible candidates for multiple sclerosis (MS) therapy. The pathogenesis of MS is unclear. One theory suggests that the development of autoimmune...

  • Analysis of Long Noncoding RNA and mRNA Expression Profiles in IL-9-Activated Astrocytes and EAE Mice. Liu, Xiaomei; Zhang, Qing; Wang, Weixiao; Zuo, Dongjiao; Wang, Jing; Zhou, Feng; Niu, Liping; Li, Xiangyang; Qin, Suping; Kou, Yanbo; Kong, Fanyun; Pan, Wei; Wang, Yugang; Gao, Dianshuai; Sun, Hong; Meves, Jessica M.; Zheng, Kuiyang; Tang, Renxian // Cellular Physiology & Biochemistry (Karger AG);Mar2018, Vol. 45 Issue 5, p1986 

    Background/Aims: Multiple sclerosis (MS) is an autoimmune disease in the central nervous system associated with demyelination and axonal injury. Astrocyte activation is involved in the pathogenesis of MS and experimental autoimmune encephalomyelitis (EAE), an animal...

  • Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation. Shrestha, Bandana; Shujun Ge; Pachter, Joel S. // Fluids & Barriers of the CNS;2014, Vol. 11 Issue 1, p1 

    Background The chemokine CCL2 is a critical mediator of neuroinflammation in diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). CCL2 drives mononuclear cell infiltration into the central nervous system (CNS), alters expression and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics